Stockreport

Aprea Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

Aprea Therapeutics, Inc.  (APRE) 
PDF DOYLESTOWN, Pa., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical-stage biopharmaceutical company devel [Read more]